Skip to content

COMPARISON OF PAIN RELIEF OF ROPIVACAINE WITH OR WITHOUT ADJUVANT IN BILATERAL SUPERFICIAL CERVICAL PLEXUS BLOCK IN THYROIDECTOMY SURGERIES IN POST OPERATIVE PERIOD

A COMPARATIVE STUDY OF POST OPERATIVE ANALGESIC EFFICACY OF BILATERAL SUPERFICIAL CERVICAL PLEXUS BLOCK WITH 0.25% ROPIVACAINE VERSUS 0.25% ROPIVACAINE WITH DEXMEDETOMIDINE 0.5 mcg/kg FOR THYROIDECTOMY UNDER GENERAL ANAESTHESIA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/02/023300
Enrollment
60
Registered
2020-02-13
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E00-E07- Disorders of thyroid gland

Interventions

Intervention1: BILATERAL SUPERFICIAL CERVICAL PLEXUS BLOCK: Post-operative analgesic efficacy is assessed and duration of study is around 1 year. Control Intervention1: 0.25% isobaric ropivacaine alon

Sponsors

JLN MEDICAL COLLEGE AJMER
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients undergoing thyroid surgery under general anaesthesia Patient age between 16 â?? 60 years ASA (American Society of Anaesthesiologists) physical status I and II

Exclusion criteria

Exclusion criteria: Age 60 years ASA physical status III, IV, V and VI. Patients not willing to participate in the study Patient with a known history of sensitivity and contraindications to drugs used Patients with a known history of chronic analgesic consumption Patients with a known history of psychiatric illness Patients non-euthyroid at the time of surgery. Patients with known coagulopathy Infection at the site of block Patients with substernal goitre Patients with stridor or respiratory compromise Patients with thyroid malignancy requiring block dissection Patients having advanced heart block Patients with severe ventricular dysfunction, and/or hypovolemia Patients with co-mobidities like diabetes mellitus or chronic hypertension

Design outcomes

Primary

MeasureTime frame
Duration of post operative analgesiaTimepoint: Duration of study is around 1 year

Secondary

MeasureTime frame
1. Total consumption of analgesic in 24h 2. Post-operative nausea and vomiting 3. Adverse effects like hematoma, intravascular injections, local anaesthetic toxicity, bradycardia, hypotension and sedationTimepoint: Duration of study is around 1 year

Countries

India

Contacts

Public ContactDr Neena Jain

Jawahar Lal Nehru Medical College, Ajmer, Rajasthan

drneenaj@gmail.com09414008666

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026